<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Biological changes more frequently associated with <z:hpo ids='HP_0003584'>late onset</z:hpo> <z:hpo ids='HP_0000716'>depressions</z:hpo>, such as cerebral <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo>, increased urinary MHPG concentrations, decreased gonadal functions, and increased MAO activity were reviewed and the therapeutic implications of these biological changes considered </plain></SENT>
<SENT sid="1" pm="."><plain>The rationale for the use of Hydergine, <z:chebi fb="0" ids="2666">amitriptyline</z:chebi>, Gerovitol H3, <z:chebi fb="0" ids="5120">fluoxymesterone</z:chebi>, <z:chebi fb="0" ids="4710">doxepin</z:chebi>, and <z:chebi fb="0" ids="9654">trazodone</z:chebi> in geropsychiatric patients was discussed </plain></SENT>
</text></document>